Subsequently, it was decided by the treating physician to try off-label treatment with the thrombopoietin (TPO) receptor agonist eltrombopag, since it has recently been reported to increase platelet counts in different forms of inherited thrombocytopenias (31). This evidence concerns the gene THPO and Thrombocytopenia.